Keep reading
Blog/Investment Banking
Corporate development case study interview questions simulate a real transaction review. A candidate receives a prompt, incomplete data, and a clock, then must decide whether a company should acquire, invest in, divest, partner with, or walk away from a target. The interviewer is not testing M&A vocabulary. They are assessing whether you can underwrite an inorganic growth decision under ambiguity and convert that work into a recommendation a CFO, investment committee, or board would act on.
That distinction matters for finance careers because corporate development sits at the intersection of strategy and capital allocation. Better answers lead to cleaner models, sharper diligence, fewer post-close surprises, and stronger judgment on which deals deserve management time.
Corporate development differs from investment banking and private equity because the buyer is strategic, not purely financial. The acquirer has an operating base, a brand, customers, channel conflicts, technology architecture, regulatory exposure, and internal politics. A technically correct model can still be the wrong answer if it ignores integration risk, return thresholds, or management distraction.
The strongest case answers sound like a short investment committee memo. They define the decision, isolate value drivers, test downside, and state what must be true to proceed. They do not over-index on valuation alone. They connect strategy, financial impact, diligence priorities, deal structure, approval path, and post-close accountability.
The practical difference is ownership. A banker can advise on price and process, but a corporate development team must live with the asset. That means the case answer should show how the company will capture value after signing, not merely how it will win an auction.
Corporate development case study interview questions usually test six capabilities at once. Interviewers want to see whether you can balance strategic logic with financial discipline under time pressure.
The right answer is rarely an unconditional yes or no. A better answer is conditional: proceed only if the target expands the enterprise customer base without channel conflict, verified synergies cover part of the premium, and customer retention risk is mitigated through structure or operating plan.
Most cases can be answered through four questions. This framework keeps the discussion anchored in decisions rather than generic M&A theory.
This structure also improves your model. Instead of one optimistic base case, show a case where synergy timing slips, integration costs rise, or retention weakens. That is how corporate development teams separate a compelling story from a verified return.
Start with decision criteria, not a valuation range. A strong answer is: “I would assess strategic fit, valuation, synergy capture, risk, and alternatives. I would proceed only if the deal creates more value than organic investment, partnership, or a smaller tuck-in.”
Clarify the acquirer’s strategy, the target’s revenue, growth, margin, customer mix, ownership, process dynamics, expected price, financing plan, and required consents. Then state a compact thesis. The acquisition is attractive if it gives the buyer a credible product where it currently loses deals and if integration can be limited in year one. It is unattractive if growth depends on founder-led sales or speculative revenue synergies.
Corporate development valuation should triangulate methods. Use a discounted cash flow analysis when cash flows are forecastable, trading comparables to calibrate the market, precedent transactions to reflect control premiums, and strategic value to capture buyer-specific upside.
Separate enterprise value vs equity value. Enterprise value reflects the operating business before financing structure. Equity value adjusts for net debt, cash, working capital, leases, minority interests, and transaction-specific items. The output should be a valuation range and a walk-away price, not a false sense of precision.
Synergy analysis is where practitioners separate themselves. Cost synergies are more controllable, such as overlapping G&A, procurement savings, vendor renegotiation, facilities consolidation, and systems consolidation. Revenue synergies need more proof because they depend on customer behavior, sales incentives, product compatibility, and timing.
Classify revenue synergies vs cost synergies by probability and timing. Day-one items include duplicate vendor contracts and public company costs. Near-term items include procurement and facilities. Medium-term items include cross-sell and pricing uplift. Speculative items include new market entry. Always model integration costs, including severance, retention bonuses, systems migration, rebranding, and advisory fees.
Accretion and dilution analysis measures the pro forma impact on earnings per share. It does not prove value creation. A deal can be accretive because cheap debt funds a low-growth asset. A deal can be dilutive while still creating value if it buys a high-return platform.
The mechanics are straightforward. Estimate the target’s after-tax earnings, add realistic net synergies, subtract incremental interest expense, include lost interest income on cash used, adjust for new shares, and compare pro forma EPS to standalone EPS. Then explain the limits. EPS ignores cash conversion, reinvestment needs, purchase accounting, execution risk, and strategic option value.
The best diligence answer is risk-based. Begin with the investment thesis and identify which facts would confirm, weaken, or kill the deal. Financial diligence should test revenue quality, margin sustainability, working capital, cash conversion, debt-like items, deferred revenue, capitalization policies, and non-recurring add-backs.
Commercial diligence should test market size, growth, customer willingness to buy, churn drivers, pricing power, and competitive response. For software targets, net revenue retention, cohort performance, implementation backlog, customer acquisition cost, and services margins often matter most. Use commercial due diligence to prove whether customers value the product independently or mainly because of discounts, founders, or integration promises.
Deal structure allocates risk when valuation and diligence cannot eliminate uncertainty. Cash gives sellers certainty and avoids buyer dilution, but consumes liquidity. Stock preserves cash and shares risk, but exposes sellers to the buyer’s share price. Mixed consideration can bridge both preferences.
Earnouts can bridge valuation gaps when future performance is uncertain. They work when metrics are objective and hard to manipulate. They fail when the buyer will integrate quickly, change accounting policies, alter sales incentives, or control the resources needed to hit the target. Escrows, holdbacks, indemnities, working capital adjustments, and retention packages also protect value.
Integration is part of underwriting, not a postscript. Decide which functions need immediate integration and which should remain separate to preserve value. Full integration suits a scale acquisition with duplicative operations. A lighter model suits technology or talent deals where bureaucracy could damage the asset.
The first 100 days should cover leadership retention, customer communication, employee messaging, finance controls, cybersecurity access, compliance, synergy tracking, and decision rights. A useful IC memo assigns each synergy to an owner and creates a baseline, so management cannot later claim value that would have happened anyway. For more detail, see the post-merger integration process.
Use a repeatable sequence when the prompt feels messy. Clarify the objective, define the deal perimeter, assess strategic fit, underwrite value, diligence the risks, choose structure, plan integration, and then recommend proceed, pause, renegotiate, or walk away.
A junior or mid-level professional can apply this directly in a live deal model or IC memo. Create one page that shows the base valuation, buyer-specific synergies, integration costs, downside case, walk-away price, and three kill tests. If the case depends on cross-sell, for example, the memo should show customer overlap, attach rate evidence, quota crediting risk, and timing to revenue recognition.
Interviewers notice when candidates jump to valuation before understanding strategy. A corporate buyer acquires capabilities, customers, assets, people, obligations, and execution risk, not only forecast EBITDA.
Interviewers also notice when candidates treat synergies as free value. Synergies require actions, costs, owners, and time. If the seller captures all synergy value through price, the buyer takes integration risk without adequate return.
Finally, interviewers penalize candidates who never make a recommendation. Balanced analysis is necessary, but corporate development roles require decisions. State what you would do based on available facts, and state what information would change your view.
A strong answer to corporate development case study interview questions is a verbal decision memo. Identify the strategic reason for the deal, quantify value without double-counting, pressure-test synergies against integration costs, isolate diligence items that change the recommendation, propose risk allocation through structure, and make a clear call. That habit improves interviews, IC discussions, and real capital allocation decisions.
P.S. – Check out our Premium Resources for more valuable content and tools to help you advance your career.
Join 80,000+ readers
One email a week: markets and finance news, the latest M&A deals and reports, investor biographies and deep dives.
Free forever. Unsubscribe anytime.
